Nitroprusside

Nipride

50 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1975

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Nipride Double 50 MG Amp.Saudi Arabia · RocheSame brand
NiprideUnited States · 50MG/VIAL · injectable · RocheSame brand
Nipride Rtu in Sodium Chloride 0.9%United States · 10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG/100ML, 50MG/100ML · solution · Exela PharmaSame brand
Nipruss 60 mg, poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · Altamedics GmbHSame substance
AnyNew Zealand · Inj 50 mg vialSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nitroprusside

Nipride

50 MG / VIAL Powder For SolutionCanadaCancelledAuthorised 31 Dec 1975

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

KetostixNew Zealand · Test strip

Sod.Nitroprusside 50MG VialSaudi Arabia · Hospira Australia

Sodium NitroprussideUnited States · 25MG/ML, 50MG/VIAL, 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · DR Reddys

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nitroprusside
Strength: 50 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1975
Registration: DIN 00336459
Marketing authorisation holder: Hospira Healthcare Ulc
ATC code: C02DD01
Group: Cardiovascular system
Supply: PRESCRIPTION

Sodium Nitroprusside for InjectionNitroprusside · 25 MG / ML · SolutionCanada

NiprideNitroprusside · 25 MG / ML · SolutionCanadaCancelled